Xencor | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Arrowhead Research USD 52.59M 132.85M 2024-12
AstraZeneca USD 41.04B 168M 2025-03
Biogen USD 16.98B 262.7M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Cytokinetics USD -135372000 121.46M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
J&J USD 78.11B 6.62B 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 48.34B 2.02B 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Xencor USD 677.61M 46.22M 2024-12



Xencor Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.